|
Market Closed -
Sao Paulo
13:30:52 2026-08-14 EDT
|
5-day change | 1st Jan Change | ||
| 92.25 BRL | +2.52% |
|
0.00% | +10.93% |
| 08-24 | FDA places clinical hold on Regenxbio's gene therapy for Hunter Syndrome | RE |
| 08-24 | Takeda's Orzeryful Approved in Japan as First Treatment Targeting Narcolepsy Type 1 | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -3.59% | -7.10% | -0.55% | +11.71% | +10.68% | +61.60% | +114.83% | +355.15% | +1,420.21% | 1,060B | |
| -1.15% | -1.25% | +2.51% | +17.30% | +30.47% | +52.98% | +62.41% | +55.80% | +126.81% | 651B | |
| -1.09% | -1.15% | +1.36% | +23.36% | +15.06% | +26.18% | +79.22% | +118.36% | +306.90% | 465B | |
| -1.06% | -2.15% | +1.03% | +9.94% | +10.85% | +38.54% | +40.38% | -0.68% | +50.33% | 365B | |
| -1.14% | -0.47% | -2.16% | +5.15% | +14.73% | +23.30% | +39.00% | +49.19% | +61.52% | 300B | |
| -0.50% | +1.03% | -5.54% | -12.79% | -11.72% | +2.54% | +12.68% | +41.89% | +145.69% | 258B | |
| -0.43% | -0.46% | +17.10% | +31.08% | +34.53% | +52.06% | +71.75% | +98.83% | +156.06% | 238B | |
| -1.84% | +1.01% | -8.38% | +3.12% | -8.02% | -16.13% | -53.73% | -7.24% | +91.03% | 210B | |
| -0.46% | +0.33% | +14.52% | +10.74% | +20.65% | +29.05% | +92.67% | +107.32% | +85.65% | 184B | |
| -0.95% | +0.21% | +15.32% | +9.48% | +13.65% | +13.56% | -22.21% | -40.27% | -18.72% | 161B | |
| -1.01% | -0.86% | +14.65% | +25.55% | +20.72% | +41.35% | +56.34% | +176.06% | +463.69% | 139B | |
| -0.52% | -0.06% | +8.83% | +16.44% | +25.27% | +43.13% | +8.84% | +0.87% | +14.97% | 138B | |
| -0.91% | -0.32% | -0.32% | +0.52% | -6.26% | -10.40% | -21.90% | -12.07% | +11.68% | 109B | |
| -0.74% | -1.59% | -3.85% | -2.05% | +3.34% | +28.31% | +34.89% | +2.02% | -8.55% | 103B | |
| -1.47% | +0.90% | +1.45% | -8.42% | -15.72% | +15.57% | +57.42% | +62.12% | +544.23% | 72.79B | |
| -0.87% | +0.69% | +0.69% | +14.80% | +20.14% | +31.96% | +29.90% | +58.50% | +29.41% | 58.71B | |
| -0.58% | +0.39% | +3.32% | +28.02% | +31.86% | +71.74% | -3.14% | +3.15% | -49.52% | 56.21B | |
| -0.58% | -11.23% | -13.02% | -5.95% | -21.96% | -29.84% | +14.17% | -1.94% | +183.98% | 45.76B | |
| -0.47% | +1.20% | +23.08% | +9.56% | +21.50% | +108.93% | +290.93% | +307.74% | -26.44% | 44.19B | |
| Average | -1.05% | -0.35% | +3.69% | +9.87% | +11.04% | +30.76% | +47.60% | +72.36% | +188.89% | 245.2B | |
| Weighted average by Cap. | -1.59% | -1.63% | +2.36% | +11.93% | +13.70% | +37.38% | +59.59% | +123.08% | +426.45% |
- Stock Market
- Stocks
- 4502 Stock
- TAKP34 Stock
- Sector Takeda Pharmaceutical Company Limited
Select your edition
All financial news and data tailored to specific country editions
